Company News

Read More
Bioactivx Shares Early Clinical Evidence and Explores New Opportunities at ISBI Congress and DFCon 2026
November 4, 2026
Read More
Bioactivx Opens New Singapore Manufacturing Facility
September 16, 2026
Read More
Bioactiv® Matrix Receives HSA Approval in Singapore
September 16, 2026
Read More
Singapore Deep-Tech Startup Bioactivx Raises US$3 Million in Latest Round to Advance New Generation of Wound Care
August 26, 2026
Read More
Bioactivx Raises US$1.425 Million Seed Round To Redefine Wound Healing With Synthetic Regenerative Implants
November 25, 2025